Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma.
Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology. 2014 Aug; 272(2):587-97.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Angiography, Digital Subtraction
Angiography, Digital Subtraction
Antineoplastic Agents
Antineoplastic Agents
Biomarkers
Biomarkers
Biopsy
Biopsy
Carcinoma, Hepatocellular
Carcinoma, Hepatocellular
Chemoembolization, Therapeutic
Chemoembolization, Therapeutic
Contrast Media
Contrast Media
Female
Female
Gadolinium DTPA
Gadolinium DTPA
Humans
Humans
Liver Function Tests
Liver Function Tests
Liver Neoplasms
Liver Neoplasms
Magnetic Resonance Angiography
Magnetic Resonance Angiography
Magnetic Resonance Imaging, Interventional
Magnetic Resonance Imaging, Interventional
Male
Male
Middle Aged
Middle Aged
Predictive Value of Tests
Predictive Value of Tests
Prospective Studies
Prospective Studies
Survival Rate
Survival Rate
Treatment Outcome
Treatment Outcome
Tumor Burden
Tumor Burden